Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of 11-valent pneumococcal conjugate vaccine in infants using a 3, 5, 12 month staggered vaccination schedule
2004-001823-39Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of 11-valent pneumococcal conjugate vaccine in pneumococcal disease and meningococcal disease (2 arms), sponsored by GSK. Started Sep 2004; status: completed.
02
Drugs
11-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal diseasemeningococcal disease
Beyond the preview
Go deeper on 2004-001823-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001823-39.